Neuromodulation
Neuromodulation: how brain circuits are modified. rTMS as a major modern application in psychiatry.
Neuromodulation is defined as the influence on neural activity through targeted delivery of physical energy — electrical, magnetic, acoustic — or chemical agents, with the aim of restoring normal neural function or therapeutically modifying it. rTMS is one of the most important forms of non-invasive neuromodulation in modern psychiatry.
Neuromodulation represents a fundamentally different therapeutic approach from pharmacology: instead of modifying chemistry, it modifies circuit physiology. This gives it advantages where pharmacology may fail — especially in treatment-resistant depression, therapeutic resistance, and disorders with clear neural circuit deficits.
Mechanism — categories of neuromodulation
1. Non-invasive
- rTMS / TMS: repetitive magnetic stimulation, the basis for rTMS in depression and other indications.
- tDCS (Transcranial Direct Current Stimulation): continuous subthreshold current; it does not directly induce action potentials but modifies membrane potential.
- tACS (Transcranial Alternating Current Stimulation): alternating current used to synchronize specific oscillations.
- Focused Ultrasound (FUS): acoustic waves targeting deeper structures without surgery.
2. Minimally invasive
- ECT (Electroconvulsive Therapy): high effectiveness in severe treatment-resistant depression; anaesthesia is required.
- MST (Magnetic Seizure Therapy): TMS-induced seizure with a more localized effect than ECT.
3. Invasive
- DBS (Deep Brain Stimulation): implanted electrodes targeting regions such as sgACC or nucleus accumbens in refractory cases.
- VNS (Vagus Nerve Stimulation): electrical stimulation of the vagus nerve, FDA-approved for long-term treatment-resistant depression.
- SCS (Spinal Cord Stimulation): used for chronic pain.
Clinical significance
The main non-invasive neuromodulation methods are applied according to diagnostic profile, previous treatments, symptom severity, and parameters such as DLPFC targeting.
Explicit relations (Entity Graph)
- Neuromodulation → broader term for → rTMS, tDCS, ECT, DBS, VNS, FUS
- rTMS → non-invasive neuromodulation → primary psychiatric application
- tDCS → used alongside → rTMS
- ECT → more effective than → rTMS in severe TRD, but with greater cognitive adverse-effect concerns
- DBS → targets → sgACC / nucleus accumbens in refractory MDD
- Neuromodulation → circuit-level mechanism → differs from pharmacological synaptic-level mechanisms
- Neuromodulation → future direction → closed-loop, biomarker-guided, personalized treatment
References
- Lefaucheur JP, Aleman A, Baeken C, et al. (2020). Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clinical Neurophysiology.
- Nitsche MA, Cohen LG, Wassermann EM, et al. (2008). Transcranial direct current stimulation: state of the art 2008. Brain Stimulation.
- Brunoni AR, Nitsche MA, Bolognini N, et al. (2012). Clinical research with transcranial direct current stimulation (tDCS). Brain Stimulation.
- Hoogendam JM, Ramakers GMJ, Di Lazzaro V (2010). Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimulation.
